Literature DB >> 7965393

Apoptosis in bladder cancer as related to standard prognostic factors and prognosis.

P K Lipponen1, S Aaltomaa.   

Abstract

Four hundred cases of transitional cell bladder cancer were reviewed by light microscopy for the presence of apoptotic cells in the primary tumour biopsy specimens. The number of apoptotic cells/mm2 of neoplastic epithelium (apoptotic index, AI) was related to various histological features and prognosis. AI was related significantly to high T-category, high grade, DNA aneuploidy, large nuclear morphometric variable values, and high proliferation rate of cancer cells. Tumours showing overexpression of p53 oncoprotein in over 10 per cent of the nuclei had significantly higher AI values than p53-negative tumours. Multivariate regression analysis showed that AI was independently predicted by mitotic index, mean nuclear area, and papillary status. Progression, recurrence-free survival, and survival of superficial tumours were all related significantly to AI. In multivariate survival analysis, T-category, papillary status, grade, and mitotic index had independent prognostic value, while the recurrence-free survival of Ta-T1 tumours was related independently to AI. The results show that AI is related particularly to mitotic activity in transitional cell bladder tumours, while AI as assessed by light microscopy hardly has any independent prognostic significance.

Entities:  

Mesh:

Year:  1994        PMID: 7965393     DOI: 10.1002/path.1711730408

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  23 in total

1.  Apoptosis detected with monoclonal antibody to single-stranded DNA is a predictor of recurrence in intracranial meningiomas.

Authors:  A Konstantinidou; P Korkolopoulou; E Patsouris; H Mahera; S Hranioti; X Kotsiakis; P Davaris
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

2.  Apoptosis in cervical squamous carcinoma: predictive value for survival following radiotherapy.

Authors:  J R Paxton; B S Bolger; A Armour; R P Symonds; J H Mao; R A Burnett
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

3.  Abl expression, tumour grade, and apoptosis in chondrosarcoma.

Authors:  M O'Donovan; J M Russell; J J O'Leary; J A Gillan; M P Lawler; E F Gaffney
Journal:  Mol Pathol       Date:  1999-12

4.  Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen.

Authors:  W F Cheng; C H Hung; C Y Chai; K F Hsu; L He; M Ling; T C Wu
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Accelerated apoptosis and low bcl-2 expression associated with neuroendocrine differentiation predict shortened survival in operated large cell carcinoma of the lung.

Authors:  A K Eerola; H Ruokolainen; Y Soini; H Raunio; P Pääkkö
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

6.  Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers.

Authors:  W Y Chan; K K Cheung; J O Schorge; L W Huang; W R Welch; D A Bell; R S Berkowitz; S C Mok
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

7.  Extent of apoptosis in ovarian serous carcinoma: relation to mitotic and proliferative indices, p53 expression, and survival.

Authors:  M E McMenamin; A J O'Neill; E F Gaffney
Journal:  Mol Pathol       Date:  1997-10

8.  Apoptosis in squamous cell carcinoma of the lung: correlation with survival and clinicopathological features.

Authors:  M Ghosh; J Crocker; A Morris
Journal:  J Clin Pathol       Date:  2001-02       Impact factor: 3.411

9.  Decreased DNA repair but normal apoptosis in ultraviolet-irradiated skin of p53-transgenic mice.

Authors:  G Li; D L Mitchell; V C Ho; J C Reed; V A Tron
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

10.  Reasons for cancer metastasis: A holistic perspective.

Authors:  Rui-An Wang; You-Yong Lu; Dai-Ming Fan
Journal:  Mol Clin Oncol       Date:  2015-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.